Merck & Co., Inc. Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31)
Merck & Co., Inc. (MRK) had Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31) of $7.30 billion as of 2009-12-31, per its 10-K filed 2011-02-28.
Discontinued › Notes › Intangible Assets
us-gaap:AcquiredFiniteLivedIntangibleAssetAmount · last filed 2011-02-28
- 2009-12-31: Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31) $7.30B.
| Period end | Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31) |
|---|---|
| 2009-12-31 | $7.30B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |